Peptide SA12 inhibits proliferation of breast cancer cell lines MCF-7 and MDA-MB-231 through G0/G1 phase cell cycle arrest

BACKGROUND: Targeted therapies have been proven as promising in the treatment of breast cancer and have improved survival and quality of life in advanced breast cancer. We previously identified a novel peptide SA12 which showed significant activity in the inhibition of proliferation and induction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Longfei, Liu, Huanran, Long, Min, Wang, Xi, Lin, Fang, Gao, Zhaowei, Zhang, Huizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935185/
https://www.ncbi.nlm.nih.gov/pubmed/29750041
http://dx.doi.org/10.2147/OTT.S154337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935185/
https://www.ncbi.nlm.nih.gov/pubmed/29750041
http://dx.doi.org/10.2147/OTT.S154337

Ejemplares similares